Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

Intertumoral Differences in Hypoxia Selectivity of the PET Imaging Agent 64Cu(II)-Diacetyl-Bis(N4-Methylthiosemicarbazone)

Hong Yuan, Thies Schroeder, James E. Bowsher, Laurence W. Hedlund, Terence Wong and Mark W. Dewhirst
Journal of Nuclear Medicine June 2006, 47 (6) 989-998;
Hong Yuan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thies Schroeder
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James E. Bowsher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurence W. Hedlund
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terence Wong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark W. Dewhirst
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    Image thresholding in area fraction measurement. (A and B) Original 64Cu-ATSM autoradiography image and EF5 fluorescent staining image. (C and D) Corresponding histograms for above images. The Otsu automatic thresholding method was used to determine the threshold based on histograms. Pixels with intensity higher than the threshold (in white color) were treated as positive uptake or staining area. (E and F) Segmented images using the Otsu threshold for autoradiography and EF5 staining image. Area in white is regarded as 64Cu-ATSM uptake area or positive staining area.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    Biodistribution of 64Cu-ATSM in tumor-bearing rat model. (A) Dynamic uptake of 64Cu-ATSM in different organs in 9L tumor-bearing rat measured from whole-body microPET. (B) Biodistribution data measured using autoradiography on organs taken from animals at 1 h after radiopharmaceutical injection in 3 tumor lines. Biodistribution data are presented as a relative uptake value for each organ normalized to muscle in each animal.

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    microPET of 3 different tumor types. (A) Typical PET image for R3230Ac with transverse, coronal, and sagittal sections. An ROI was drawn in transverse section to measure the uptake level. For each tumor, measurements were taken in 4 ROIs and averaged, representing an overall uptake level. (B) Dynamic uptake of 64Cu-ATSM in 3 tumors including R3230Ac (n = 8), 9L (n = 7), and FSA (n = 7). Uptake value in muscle was taken from R3230Ac animals.

  • FIGURE 4. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4. 

    Typical immunostaining of EF5 binding in tumor tissues (R3230Ac). Dual fluorescence images (A) are overlaid to show distribution of hypoxia relative to vasculature. Hypoxic tissue is indicated by EF5 staining in orange. Vasculature is indicated by the Hoechst 33342 perfusion marker in blue. (B) A whole tumor section staining image was generated by stitching together images from microscope stage scans.

  • FIGURE 5. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5. 

    Comparisons between 64Cu-ATSM uptake and hypoxia measured by immunostaining in R3230Ac and FSA. Close correlation between 64Cu-ATSM uptake and EF5-stained hypoxic area was observed in R3230Ac tumor (left), whereas no correlation was found in FSA tumor (right). Images include 64Cu-ATSM microPET image, autoradiography (AR) section from same tumor, EF5 and Hoechst immunostaining from adjacent section, fused image from autoradiography and EF5 images, H&E staining, and correlation plot between autoradiography and EF5 staining images. EF5-stained hypoxic area is indicated by orange, perfused vessels are marked by blue fluorescent Hoechst 33342 dye, and 64Cu-ATSM distribution in AR is indicated by green in fused image. In FSA, a large amount of 64Cu-ATSM accumulated in well-perfused areas, which are indicated in Hoechst perfusion image. The spatial correlation between autoradiography and EF5 staining images in this specific FSA tumor is 0.05, whereas the spatial correlation is 0.78 in the shown R3230Ac tumor.

  • FIGURE 6. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6. 

    CA-IX and pimonidazole staining on FSA and R3230Ac tumor sections. (A and B) 64Cu-ATSM autoradiography (AR) and CA-IX staining (green) on same FSA tumor section (in same tumor as shown in Fig. 5, FSA panel). CA-IX staining shows a hypoxia distribution that is consistent with EF5 staining. (C and D) 64Cu-ATSM autoradiography and pimonidazole staining (orange) with Hoechst 33342 vascular perfusion marker (blue) illustrate low correlation between 64Cu-ATSM and this hypoxia marker in FSA. (E and F) 64Cu-ATSM autoradiography and pimonidazole staining in R3230Ac tumor. Close correlation can be seen between 64Cu-ATSM uptake and pimonidazole staining.

  • FIGURE 7. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7. 

    64Cu-ATSM distribution in response to oxygenation. FSA-bearing rats breathed carbogen for 3 h before and during microPET. (A) 64Cu-ATSM autoradiography image. (B) EF5 binding (orange) and Hoechst perfusion (blue) fluorescent staining image for the neighboring tumor section from same animal. There is no correlation between 64Cu-ATSM uptake and hypoxia marked by EF5 binding. A significant decrease in EF5 staining, but not uptake of 64Cu-ATSM, was found in carbogen-breathing animal group (Table 3).

Tables

  • Figures
    • View popup
    TABLE 1

    Animal Parameters, Radioactivity Dosage, and 64Cu-ATSM Uptake in 3 Tumor Lines

    TumorAnimal weight (g)Tumor volume (cm3)Dose (MBq)SUV*T/M ratio†
    R3230Ac (n = 8)179.00 ± 6.865.59 ± 1.7426.5 ± 2.71.31 ± 0.112.29 ± 0.22
    9L (n = 7)225.86 ± 7.467.17 ± 2.1325.0 ± 2.11.64 ± 0.11‡3.43 ± 0.22‡
    FSA (n = 7)154.14 ± 8.874.81 ± 1.2026.1 ± 2.52.04 ± 0.10¶5.33 ± 0.25¶
    • ↵* SUV is value at 1 h after injection of 64Cu-ATSM.

    • ↵† T/M ratio is taken at 1 h after injection of 64Cu-ATSM.

    • ↵‡ P < 0.05 (9L vs. R3230Ac).

    • ↵¶ P < 0.001 (FSA vs. R3230Ac/9L).

    • Data are presented as mean ± SEM.

    • View popup
    TABLE 2

    Comparison Between 64Cu-ATSM Uptake and EF5 Immunostaining

    Tumor64Cu uptake area fraction*EF5 staining area fractionSpatial correlation*
    R3230Ac (n = 8)0.239 ± 0.0360.207 ± 0.0250.74 ± 0.02, P < 0.001
    9L (n = 7)0.166 ± 0.0670.208 ± 0.0510.61 ± 0.04, P < 0.001
    FSA (n = 7)0.442 ± 0.0940.165 ± 0.041†0.11 ± 0.03, P = 0.2
    • ↵* 64Cu-ATSM autoradiography images were used for area fraction and spatial correlation analysis. Area fraction is defined as ratio of positive staining or uptake region to overall viable tissue.

    • ↵† P < 0.05, significant difference between 64Cu-ATSM uptake and EF5 staining area fractions for FSA.

    • Data are presented as mean ± SEM.

    • View popup
    TABLE 3

    Uptake of 64Cu-ATSM and EF5 Staining in Air-Breathing and Carbogen-Breathing Animals Bearing FSA Tumor

    TumorSUV64Cu uptake area fractionEF5 staining area fraction
    FSA (n = 7) (air)2.39 ± 0.360.442 ± 0.0940.165 ± 0.041*
    FSA (n = 3) (carbogen)4.20 ± 1.240.615 ± 0.1500.076 ± 0.049*
    Significance†P = 0.09P = 0.23P < 0.05
    • ↵* P < 0.05, significant difference between 64Cu-ATSM uptake and EF5 staining.

    • ↵† Significance level between air-breathing and carbogen-breathing animals (Student t test).

    • Data are presented as mean ± SEM.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 47 (6)
Journal of Nuclear Medicine
Vol. 47, Issue 6
June 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Intertumoral Differences in Hypoxia Selectivity of the PET Imaging Agent 64Cu(II)-Diacetyl-Bis(N4-Methylthiosemicarbazone)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Intertumoral Differences in Hypoxia Selectivity of the PET Imaging Agent 64Cu(II)-Diacetyl-Bis(N4-Methylthiosemicarbazone)
Hong Yuan, Thies Schroeder, James E. Bowsher, Laurence W. Hedlund, Terence Wong, Mark W. Dewhirst
Journal of Nuclear Medicine Jun 2006, 47 (6) 989-998;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Intertumoral Differences in Hypoxia Selectivity of the PET Imaging Agent 64Cu(II)-Diacetyl-Bis(N4-Methylthiosemicarbazone)
Hong Yuan, Thies Schroeder, James E. Bowsher, Laurence W. Hedlund, Terence Wong, Mark W. Dewhirst
Journal of Nuclear Medicine Jun 2006, 47 (6) 989-998;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Addressing Biological Questions with Preclinical Cancer Imaging
  • 64Cu-ATSM Reflects pO2 Levels in Human Head and Neck Cancer Xenografts but Not in Colorectal Cancer Xenografts: Comparison with 64CuCl2
  • Oxygen-Enhanced MRI Is a Major Advance in Tumor Hypoxia Imaging
  • Comparison of the Hypoxia PET Tracer 18F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models
  • On the Destiny of (Copper) Species
  • A Comparison of the Behavior of 64Cu-Acetate and 64Cu-ATSM In Vitro and In Vivo
  • Heterogeneity in Intratumor Correlations of 18F-FDG, 18F-FLT, and 61Cu-ATSM PET in Canine Sinonasal Tumors
  • Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics
  • Imaging hypoxia in gliomas
  • Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging
  • NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment
  • PET of Hypoxia with 89Zr-Labeled cG250-F(ab')2 in Head and Neck Tumors
  • Retention of the Radiotracers 64Cu-ATSM and 64Cu-PTSM in Human and Murine Tumors Is Influenced by MDR1 Protein Expression
  • Noninvasive 64Cu-ATSM and PET/CT Assessment of Hypoxia in Rat Skeletal Muscles and Tendons During Muscle Contractions
  • Applications of Nitroimidazole In Vivo Hypoxia Imaging in Ischemic Stroke
  • Google Scholar

More in this TOC Section

  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
  • Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
  • Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire